The performance of patients with Parkinson’s disease on the Face-Name Associative Memory Examination
- 83 Downloads
In this study, we examined the performance of patients with Parkinson’s disease (PD) with different cognitive profiles on the Face-Name Associative Memory Examination (FNAME). We evaluated 71 patients with a comprehensive neuropsychological battery. The results revealed that the group with executive and additional visuospatial deficits demonstrated significantly lower scores on FNAME. This finding indicates the possible clinical utility of FNAME for screening patients with PD with distinct cognitive profiles. Further longitudinal studies are needed to consider the prognostic adequacy of FNAME in detecting high-risk Parkinson’s disease dementia (PDD).
KeywordsFace-Name Associative Memory Examination Parkinson’s disease Cognitive impairment Visuospatial functions Executive functions
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The Ethics Committee of Aeginition Hospital, National and Kapodistrian University of Athens, approved the study protocol using the principles outlined in the Declaration of Helsinki.
All participants were informed of the study purpose, and they signed a written informed consent form before they participated.
- 10.Partington JE, Leiter RG (1949) Partington’s pathway test. Psychol Service Center Bull 1:9–20Google Scholar
- 13.Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique (Les problems.). Archives de Psychologie 28:215–285Google Scholar
- 14.Aretouli E, Kosmidis MH (2007) Rey–Osterrieth Complex Figure Test: Greek norms and cultural and demographic influences. Paper accepted to the 9th European Conference on Psychological Assessment & 2nd International Conference of the Psychological Society of Northern GreeceGoogle Scholar
- 15.Kormas C, Megalokonomou A, Zalonis I, Evdokimidis I, Kapaki E, Potagas C (2018) Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals. Clin Neuropsychol 2:1–12. https://doi.org/10.1080/13854046.2018.1495270 CrossRefGoogle Scholar
- 16.Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefGoogle Scholar